Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Shao Zhi Fu"'
Publikováno v:
Cancer Medicine, Vol 11, Iss 23, Pp 4457-4468 (2022)
Abstract Tumors are presently a major threat to human life and health. Malignant tumors are conventionally treated through radiotherapy and chemotherapy. However, traditional therapies yield unsatisfactory results due to high toxicity to the normal c
Externí odkaz:
https://doaj.org/article/dedb1076c4dc4e8883dd005f0616d251
Autor:
Rong-Sheng Qin, Zhen-Hua Zhang, Neng-Ping Zhu, Fei Chen, Qian Guo, Hao-Wen Hu, Shao-Zhi Fu, Shan-Shan Liu, Yue Chen, Juan Fan, Yun-Wei Han
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-12 (2018)
Abstract Background Conventional chemotherapy is commonly used to treat non-small cell lung cancer (NSCLC) however it increases therapeutic resistance. In contrast, metronomic chemotherapy (MET) is based on frequent drug administration at lower doses
Externí odkaz:
https://doaj.org/article/fadad5f44f8742cba01961c77e361a3e
Autor:
Rui-Lin Ding, Fang Xie, Yue Hu, Shao-Zhi Fu, Jing-Bo Wu, Juan Fan, Wen-Feng He, Yu He, Ling-Lin Yang, Sheng Lin, Qing-Lian Wen
Publikováno v:
Drug Delivery, Vol 24, Iss 1, Pp 300-308 (2017)
The purpose of this study was to prepare ES-loaded chitosan nanoparticles (ES-NPs) and evaluate the antitumor effect of these particles on the Lewis lung cancer model. ES-NPs were prepared by a simple ionic cross-linking method. The characterization
Externí odkaz:
https://doaj.org/article/59fdaca7cfd74d6fb6026e44af086352
Autor:
Fang Xie, Rui-Lin Ding, Wen-Feng He, Zong-Jun-Lin Liu, Shao-Zhi Fu, Jing-Bo Wu, Ling-Lin Yang, Sheng Lin, Qing-Lian Wen
Publikováno v:
Drug Delivery, Vol 24, Iss 1, Pp 1410-1418 (2017)
The purpose of this study was to prepare endostatin-loaded chitosan nanoparticles (ES-NPs) and evaluate their antitumor effect when combined with paclitaxel (PTX) on Lewis lung carcinoma (LLC) mouse xenografts. ES-NPs were prepared by ionic cross-lin
Externí odkaz:
https://doaj.org/article/562dd494286a45669f8ff5f8aa210576
Autor:
Xiao Ling Ni, Long Xia Chen, Heng Zhang, Bo Yang, Shan Xu, Min Wu, Jing Liu, Ling Lin Yang, Yue Chen, Shao Zhi Fu, Jing Bo Wu
Publikováno v:
Drug Delivery, Vol 24, Iss 1, Pp 1501-1512 (2017)
Gefitinib (GEF) is the first epidermal growth factor receptor (EGFR)-targeting agent launched as an anticancer drug. It is an accepted opinion that modifying GEF strong hydrophobicity and poor bioavailability would not only enhance its antitumor effe
Externí odkaz:
https://doaj.org/article/5fb5f745834a41a791beb1c606705b24
Publikováno v:
Materials Research Express, Vol 8, Iss 4, p 045001 (2021)
CuFeSe _2 nanomaterial with high thermal conversion efficiency, well superparamagnetism, effective x-ray attenuation ability, multifunctional groups and excellent biocompatibility is beneficial to the construction of multimodal imaging probes which c
Externí odkaz:
https://doaj.org/article/ede4a06639404b64a13f730453cbae2d
Autor:
Zong-Jun-Lin Liu, Yu-Juan Zhou, Rui-Lin Ding, Fang Xie, Shao-Zhi Fu, Jing-Bo Wu, Ling-Lin Yang, Qing-Lian Wen
Publikováno v:
PLoS ONE, Vol 13, Iss 7, p e0200845 (2018)
The effect of apatinib on the formation of vasculogenic mimicry (VM) was studied in a malignant melanoma cell line. MUM-2B cells cultured in three-dimensional Matrigel were treated with varying concentrations (0, 0.01, 0.05, 0.1, 0.5 μmol/L) of apat
Externí odkaz:
https://doaj.org/article/c5fed6df1d7c40db8cf104060717828b
Publikováno v:
International Journal of Nanomedicine
Background Radiotherapy (RT), one of the main treatments for cervical cancer, has tremendous potential for improvement in the efficacy. Poly (ADP-ribose) polymerase (PARP) is a key enzyme in the repair of DNA strand breaks (DSB). Olaparib (Ola) is a
Publikováno v:
Materials Research Express. 8:045001
CuFeSe2 nanomaterial with high thermal conversion efficiency, well superparamagnetism, effective x-ray attenuation ability, multifunctional groups and excellent biocompatibility is beneficial to the construction of multimodal imaging probes which can
Autor:
Bo Yang, Yue Chen, XiaoLing Ni, Yu Jiang, Min Wu, Linglin Yang, LongXia Chen, Xu Shan, Juan Fan, Heng Zhang, Shao Zhi Fu, Jing Bo Wu, Jing Liu
Publikováno v:
Journal of biomedical nanotechnology. 14(1)
Norcantharidin (NCTD), the demethylated analogue of cantharidin, has been confirmed to have a good anti-tumor effect against hepatocellular carcinoma (HCC). However, its use is limited by its poor water solubility and low tumortargeting efficacy. In